Role of IL-10 in allergen-specific immunotherapy and normal response to allergens (Q34374552)

1 August 2017

1 reference

title

Role of IL-10 in allergen-specific immunotherapy and normal response to allergens (English)

1 reference

1 August 2017

1 reference

C A Akdis

1

1 reference

PubMed ID

11564436

1 August 2017

K Blaser

series ordinal

2

1 reference

1 August 2017

1 September 2001

1 reference

1 August 2017

Microbes and Infection

1 reference

1 August 2017

3

1 reference

1 August 2017

891-898

1 reference

1 August 2017

11

1 reference

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Lymphokine production by human T cells in disease states

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Lymphocyte responses and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Effects of peptide therapy on ex vivo T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Determinants and mechanisms of human immune responses to bee venom phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Treatment of cat allergy with T-cell reactive peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Nasal immunotherapy in weed-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Induction of hapten-specific tolerance by interleukin 10 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Maintenance of clonal anergy by endogenously produced IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

IL-10: a potential therapy for allergic inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

CD40 expression by human peripheral blood eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

PI 3-kinase: a pivotal pathway in T-cell activation?

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Functional regions of the mouse interleukin-10 receptor cytoplasmic domain

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Identification and functional characterization of a second chain of the interleukin-10 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

Molecular basis of T cell inactivation by CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2801%2901449-6

7 January 2021

10.1016/S1286-4579(01)01449-6

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11564436